New Zealand Gazette – 2008 – No. 22

Page 506

✨ Classification of Medicines

506

NEW ZEALAND GAZETTE, No. 22

over 2 years of age except when sold at a transport terminal or aboard a ship or plane

Diphenylpyraline; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active substances either when in the bedtime dose of a day-night pack containing diphenylpyraline or when at least one of the other therapeutically active substances is a sympathomimetic decongestant

Doxylamine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active substances either when in the bedtime dose of a day-night pack containing doxylamine or when at least one of the other therapeutically active substances is a sympathomimetic decongestant

Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 200 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 0.5% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or 12 suppositories or less per pack

Ibuprofen; for oral use in liquid form in packs containing not more than 4 grams in medicines which have received the consent of the Minister or the Director-General to their sale as pharmacy-only medicines and which are sold in the manufacturer’s original pack; for oral use in solid dose form containing not more than 200 milligrams per dose form and with a recommended daily dose of not more than 1200 milligrams and in packs containing not more than 100 tablets or capsules and when in medicines which have received the consent of the Minister or the Director-General to their sale as pharmacy-only medicines and which are sold in the manufacturer’s original pack; except in packs containing 200 milligrams or less per oral solid dose form and not more than 25 dose units per pack when in medicines which have received the consent of the Minister or the Director-General to their sale as general sale medicines and which are sold in the manufacturer’s original pack

Lithium; for dermal use in medicines containing 1% or less but more than 0.01%; except when present as an excipient in dermal medicines containing 0.25% or less

Lobeline; except when in medicines for smoking or burning

Mepyramine; for dermal use

Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 200 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

Oxiconazole; for dermal use except in medicines for tinea pedis only

Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams; in slow release forms containing 665 milligrams or less and more than 500 milligrams; in powder form containing not more than 1000 milligrams per sachet and more than 10 grams per pack

Pheniramine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active substances either when in the bedtime dose of a day-night pack containing pheniramine or when at least one of the other therapeutically active substances is a sympathomimetic decongestant

Promethazine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other active substances either when in the bedtime dose of a day-night pack containing promethazine or when at least one of the other therapeutically active substances is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or plane

Pyrithione zinc; for treatment of the scalp in medicines containing more than 2%

Selenium; for oral use in medicines containing 300 micrograms or less and more than 150 micrograms per recommended daily dose; for external use except in medicines containing 3.5% or less of selenium sulfide

Triamcinolone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 55 micrograms per actuation and when the maximum recommended daily dose is no greater than 220 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

Trimeprazine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active substances either when in the bedtime dose of a day-night pack containing trimeprazine or when at least one of the other therapeutically active substances is a sympathomimetic decongestant

Triprolidine; for oral use in medicines for adults and children over 2 years of age when combined in the same container with one or more other therapeutically active substances either when in the bedtime dose of a day-night pack containing triprolidine or when at least one of the other therapeutically active substances is a sympathomimetic decongestant

Medicines for General Sale

Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale.

Benzydamine; for dermal use

Choline salicylate; in medicines containing 10% or less and in pack sizes of 15 grams or less

Etidronic acid; in medicines for external use containing 1% or less

Liquorice, deglycyrrhizinised

Lithium; for dermal use in medicines containing 0.01% or less; when present as an excipient in medicines for dermal use containing 0.25% or less

Lobeline; in medicines for smoking or burning

Methyl salicylate; for external use; for internal use when present as an excipient in medicines containing 1.04% or less per dose form

VUW Te Waharoa — NZ Gazette 2008, No 22

Gazette.govt.nz — NZ Gazette 2008, No 22

Parliament House (depicted) was completed in 1918 and remains the primary seat of Parliament.

✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

Domain🏥 Health & Social Welfare
Dated8 February 2008
KeywordsMedicines Act 1981, Classification, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines

As the Gazette has been published for more than 185 years, copyright status depends on the publication date of each issue:

1840–1925 (Public Domain): Issues of the New Zealand Gazette and Provincial Gazettes from this period are in the public domain, as the term of Crown copyright (100 years) has expired. Mechanical reproductions (e.g., scanned PDFs) of these public domain documents do not attract new copyright.
1926–1999 (Crown Copyright): Issues from this period remain subject to Crown copyright. Usage of these issues in this project is "Fair Dealing" for research purposes and consistent with the spirit of the open-access principles championed by NZGOAL, ie, "The default licensing position under ... NZGOAL is the Creative Commons Attribution 4.0 International licence ... [t]o the greatest extent possible, agencies should apply this licence to copyright material on their websites"
2000–Present (CC-BY 3.0 NZ): Gazette issues published on gazette.govt.nz are Crown copyright but are explicitly licensed by the Department of Internal Affairs under the Creative Commons Attribution 3.0 New Zealand licence (CC-BY 3.0 NZ). This project redistributes this content in accordance with those terms.

Nothing in this project is intended to infringe copyright, trademark law or personal privacy. Please contact me immediately if you have any concerns.

Third-Party Content

Where third-party content (e.g., notices submitted by external organisations) is identified within the Gazette, users should satisfy themselves regarding the copyright status of that specific content, as it may be subject to different ownership terms than the Gazette itself.

Sources and Attribution

NZ Gazette Sources

The primary sources for the issues of the NZ Gazette indexed by this project are:

New Zealand Gazette Archive, provided by Victoria University Library, copyright 2008 LexisNexis NZ Limited, Crown Copyright of New Zealand Gazette Office
- Issues from 1841-2008, including the New Munster, New Ulster, and Provincial Gazettes
New Zealand Gazettes by New Zealand Legal Information Institute (note: "NZLII is not the copyright owner in the source documents published on NZLII")
- Issues from 1913-1999
Gazette.govt.nz, Crown copyright / licensed by the Department of Internal Affairs under CC-BY 3.0 NZ
- Issues from 2000-2017

Additional Sources

Wellington City Recollect have made available a comprehensive and excellent-quality scan of the Wellington Provincial Gazette which was used to fill in a number of issues missing from Victoria University's Gazette Archive; in particular, all 1856 issues, issues 22-34 for 1864 and issues 9-19 for 1870.
27 issues of The New Zealand Advertiser and Bay of Islands Gazette (1840) were sourced from Papers Past (public domain).
Gazette Extraordinary No. 1 (1840), held at the Alexander Turnbull Library, Wellington, New Zealand. Imaged by Luke Howison at the National Library reading rooms; PDF released into the public domain.

PDF Icon

The PDF PDF Icon was made by Good Ware, CC BY-SA 4.0.

Masthead

The logo in the header is an edited version of “Winning Coat of Arms Competition Entry, 1908” by Archives New Zealand, CC BY 2.0 (found via Wikipedia).

Who made this?

I'm Luke Howison, a freelance web developer with an interest in genealogy. I have created several websites for genealogical research, such as NZ Ancestor Search Helper.

New Zealand Gazette Index